contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-0110-scandinavian-medical-solutions-curasight-sampo-og-norden

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Analyst

Philip Coombes

Scandinavian Medical Solutions is a Danish-based trading company specialized in purchase and resale of used diagnostic imaging equipment such as CT scanners and MR scanners of high quality. Scandinavian Medical Solutions is specialized in offering flexible solutions for customers with specific demands, which is often a better and cheaper alternative to a new and more expensive produced OEM-equipment.

Scandinavian Medical Solutions was founded in 2018, and the company has been listed at Nasdaq First North in Denmark since November 2021.

Scandinavian Medical Solutions

Curasight is a Danish biotech company focusing on developing and improving the detection and treatment of cancer in a more gentle and efficient way. The company has two pipeline products that both use radionuclide (nuclear medicine) to facilitate better diagnosis and treatment of various cancer types; uTRACE use the so-called uPAR as a biomarker to diagnose the aggressiveness of cancer, and uTREAT use the uPAR as a attachment to treat the cancer.

Based on good phase 2 data that has already been collected or will be in the first half of 2022, Curasight is expected to prepare phase 3 for uTRACE later in 2022 and 2023 for the following four cancer types: prostate, brain, neuroendocrine, and head and neck cancer.

Curasight

NORDEN is an internationally operating shipping company with 12 global offices, headquartered in Copenhagen, Denmark, and listed on  Nasdaq OMX Copenhagen. The company is present in the dry cargo and product tanker markets with a combination of operator and asset trading activities.

NORDEN’s trading-oriented business model is based on the two business units ‘Assets & Logistics’ and ‘Freight Services & Trading’ – dividing the business into asset trading and operator activities.

The company’s business activities are based on an asset-light trading strategy, only owning a small percentage (~5%) of its total operated vessel fleet consisting of close to 500 vessels. The agility of the business model enables NORDEN to continuously adjust short-term market exposure towards dry cargo and product tanker market developments while capitalizing on asset trading opportunities. In-house data and advanced analytics, risk management, and market research provide a data-driven approach to shipping, making proactive use of volatile markets.

D/S Norden

Dagens aktienyheder med Scandinavian Medical Solutions, Curasight, Sampo og NORDEN

Scandinavian Medical Solutions (SMS) offentliggjorde i g&#xe5;r, sidste dag i &#xe5;rsregnskabet for 2024/25, to ordrer der faldt i intervallet p&#xe5; henholdsvis DKK 2-3,5 mio., og DKK 3,5-5,0 mio. I forhold til forrige &#xe5;r betyder, at SMS leveret en encifret v&#xe6;kst i de annoncerede ordrer. Det stemmer godt overens med selskabets guidance, der m&#xe5;lt p&#xe5; midten af intervallet, peger p&#xe5; en flad toplinjev&#xe6;kst. L&#xe6;s mere om den samlede ordreindgang og guidance her:&#xa0;<a href="https://www.inderes.dk/analyst-comments/scandinavian-medical-solutions-2-ordrer-pa-sidste-dag-i-202425" target="_blank" rel="noopener">https://www.inderes.dk/analyst-comments/scandinavian-medical-solutions-2-ordrer-pa-sidste-dag-i-202425</a>
Curasight meddelte her til morgen, at et nyt amerikansk patent for selskabets uPAR-billeddiagnostiske platform uTRACE&#xae; er blevet udstedt, hvilket udvider beskyttelsen og forl&#xe6;nger patentets l&#xf8;betid med 751 dage fra 2033 til nu 2035. Den styrkede IP-position underst&#xf8;tter b&#xe5;de samarbejdet med Curium inden for prostatakr&#xe6;ft og theranostikplatformens potentiale p&#xe5; tv&#xe6;rs af andre kr&#xe6;ftindikationer.
Sampo er her til morgen ude med meldingen om at den nye CEO Morten Thorsrud, der blev annonceret i juni, fra i dag overtager ansvaret efter tidligere CEO Torbj&#xf6;rn Magnusson. Samtidig meddeles det at CFO Knut Arne Alsaker fratr&#xe6;der ved udgangen af marts 2026 og hans rolle overtages af Lars Kufall Beck der er tidligere CFO i Topdanmark og nuv&#xe6;rende COO i If Forsikring.
NORDEN har udnyttet en Panamax-k&#xf8;bsoption og efterf&#xf8;lgende solgt skibet, med levering forventet i 1. kvartal 2026.
Disclaimer: <a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:54143576" data-guid="52" data-object-urn="urn:li:organization:54143576" data-original-text="HC Andersen Capital" data-test-ql-mention="true">HC Andersen Capital</a> modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale. /Philip Coombes d. 01/10-2025 kl. 9:21.

HC Andersen Capital

<ul>
<li>Scandinavian Medical Solutions (SMS) annoncerede to ordrer på sidste dag i regnskabsåret 2024/25, hvilket resulterede i en encifret vækst i ordrer, der er i tråd med selskabets guidance om flad toplinjevækst.</li>
<li>Curasight har fået udstedt et nyt amerikansk patent for deres uPAR-billeddiagnostiske platform uTRACE®, hvilket forlænger patentets løbetid til 2035 og styrker deres IP-position inden for prostatakræft og andre kræftindikationer.</li>
<li>Sampo har i dag fået ny CEO, Morten Thorsrud, mens CFO Knut Arne Alsaker vil fratræde i marts 2026 og erstattes af Lars Kufall Beck.</li>
<li>NORDEN har udnyttet en Panamax-købsoption og solgt skibet med levering forventet i første kvartal 2026.</li>
</ul>Dette indhold er genereret af AI. Du kan give feedback om det på Inderes <a href="https://forum.inderes.com/t/inderes-fi-sisallon-kehitysideat/71/last">forum</a>.

Dagens aktienyheder 01/10: Scandinavian Medical Solutions, Curasight, Sampo og NORDEN

Summary

Stay up to date